Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Benefits Of Tech Transfer Reported

by Glenn Hess
November 9, 2009 | A version of this story appeared in Volume 87, Issue 45

The biotechnology industry says a new study provides evidence of the importance of university and industry R&D partnerships to the U.S. economy. The study of university technology licensing from 1996 to 2007 shows a $187 billion impact on the U.S. gross national product—a measure of the nation's output of goods and services. The licensing activity added $457 billion to gross industrial output, according to the Biotechnology Industry Organization, the industry trade group that funded the study. A 1980 law—the Bayh-Dole Act—allows university inventors to patent their discoveries and license them to commercial partners. "Because of this inspired piece of legislation, the U.S. leads the world in commercializing university-based research to create new companies and good, high-paying jobs throughout the country," BIO President James C. Greenwood says. The study also found that university-licensed products commercialized by industry created at least 279,000 new jobs across the U.S. during the 12-year period. Before passage of Bayh-Dole, inventions arising from billions of taxpayer dollars invested annually in university research were rarely commercialized because of restrictive patenting and licensing practices, the report notes.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.